An interventional study of guided imagery in Chemotherapy-induced Nausea and Vomiting and Pediatric Cancer, sponsored by Baskent University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 7 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-05-01.
Sponsored by Baskent University · Not applicable, Interventional, and Prevention
The goal of this randomized controlled study is to assess the effect of guided imagery on chemotherapy-related nausea and vomiting in pediatric oncology patients.
Participants will receive either guided imagery+routine care or routine care. The researchers will compare nausea and vomiting and vital signs between groups.
Despite significant advances in anti-emetic treatment, chemotherapy induced nausea and vomiting (CINV) is considered a major side-effect that significantly reduces the quality of life of children diagnosed with cancer. Guided imagery is one of the methods of distraction that allows the individual to go to an environment or scene that will make the individual comfortable, peaceful, happy, and focused. In this study, the participants will be randomized in a single blind manner (participant) to either intervention or control groups.
793 studies on the registry are indexed under Vomiting; 99 are open to participants now.
This study's planned enrollment of 40 is below the median of 103 across 673 interventional studies indexed under Vomiting.
Browse Vomiting studies →Baskent University is the lead sponsor of 209 studies on the registry; 35 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will receive guided imagery intervention.
Other: guided imagery
Participants will receive routine care.
The children in the experimental group will listen to the first part of the 'Guided Imagery CD' prepared by the Turkish Psychological Association for relaxation 30 minutes before the chemotherapy infusion starts. The suggestions given in the first part of the CD will help the patients relax and focus their attention on their breathing. Patients will be positioned in a supine or semi-fowler position and will listen to the CD with headphones from a laptop. Once the chemotherapy infusion starts, relaxing light background music with the sound of a river or sea will be played based on the patients' preference, and imagery will be applied to the patients. Patients will be encouraged to think of various images, such as imagining that the treatment is over, visualizing themselves as much healthier and recovering quickly, returning to their old life, and doing whatever they want to do first after recovery. If there is an object, person, event, situation, or food that will make them feel good,
Nausea and vomiting
Nausea and Vomiting Thermometer Scale in Children with Cancer is a 5-likert type scale. An increase in the score indicates an increase in the degree of nausea and vomiting experienced by children with cancer.
Time frame: 30 minutes before the procedure, halfway through the chemotherapy infusion, immediately after the procedure, and for the first 24 hours after the end of chemotherapy
Heart rate
Maintaining or normalizing heart rate within normal range (60 to 110 bpm)
Time frame: 30 minutes before the procedure, halfway through the chemotherapy infusion, and immediately after the procedure,
Systolic and diastolic blood pressure
Maintaining or normalizing systolic and blood pressure within normal range (systolic: 90-120 mmHg; diastolic 60-80 mmHg)
Time frame: 30 minutes before the procedure, halfway through the chemotherapy infusion, and immediately after the procedure
Respiratory rate
Maintaining or normalizing respiratory rate within normal range (18-30 breath per minute)
Time frame: 30 minutes before the procedure, halfway through the chemotherapy infusion, and immediately after the procedure
Body temperature
Maintaining or normalizing body temperature within normal range (36-37 C° in tympanic measurement)
Time frame: 30 minutes before the procedure, halfway through the chemotherapy infusion, and immediately after the procedure
Oxygen saturation
Maintaining or normalizing oxygen saturation within normal range (between 95%-100% by pulse oximetry)
Time frame: change from baseline 60 minutes of chemotherapy infusion
Plan to share: No — the data wil be shared upon a reasonable request.
No publications or documents are linked to this record.
Started Nov 2023 (actual). Primary completion is estimated for Sep 2026, 34 months after the start.
Of 131 non-industry interventional studies with no phase under Vomiting, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 29. This study's planned 34 months is above that.
Counting every sponsor, half of 134 studies reached it within 13 months; a quarter within 6 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.